alpha-2A Adrenergic R/ADRA2A Antibody (1006614) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # FAB10129JF635
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 635
Antibody Source
Monoclonal Mouse IgG1 Clone # 1006614
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Synthetic peptide containing Human alpha‑2A Adrenergic R/ADRA2A
Specificity
Detects human alpha‑2A Adrenergic R/ADRA2A in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for alpha-2A Adrenergic R/ADRA2A Antibody (1006614) [Janelia Fluor® 635]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: alpha-2A Adrenergic R/ADRA2A
Long Name
Alpha-2A Adrenergic Receptor
Alternate Names
a-2A AdrenergicR, ADRA2A, alpha2A AdrenergicR, ZNF32
Additional alpha-2A Adrenergic R/ADRA2A Products
Product Specific Notices for alpha-2A Adrenergic R/ADRA2A Antibody (1006614) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...